<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-14T04:44:23Z</responseDate><request verb="GetRecord" identifier="oai:www.recercat.cat:11351/13045" metadataPrefix="oai_dc">https://recercat.cat/oai/request</request><GetRecord><record><header><identifier>oai:recercat.cat:11351/13045</identifier><datestamp>2025-10-24T10:26:13Z</datestamp><setSpec>com_2072_378070</setSpec><setSpec>com_2072_378040</setSpec><setSpec>col_2072_378092</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
   <dc:title>Proposal of an Integrated Patient Journey roadmap for the introduction of the first gene therapy for haemophilia B in Spain – The BHEMOGEN project</dc:title>
   <dc:creator>Bonanad, Santiago</dc:creator>
   <dc:creator>Herrera, Concha</dc:creator>
   <dc:creator>Rodriguez Lopez, Manuel</dc:creator>
   <dc:creator>García-Diego, Daniel-Aníbal</dc:creator>
   <dc:creator>García, S</dc:creator>
   <dc:creator>Álvarez Román, María Teresa</dc:creator>
   <dc:creator>Montoro-Ronsano, J. Bruno</dc:creator>
   <dc:contributor>Institut Català de la Salut</dc:contributor>
   <dc:contributor>[Álvarez-Román MT, García S] La Paz University Hospital, Madrid, Spain. [Bonanad S] La Fe University and Polytechnic Hospital, Valencia, Spain. [Herrera C] Reina Sofía General University Hospital, Córdoba, Spain. [Rodríguez López M] Álvaro Cunqueiro University Hospital, Vigo, Spain. [García-Diego DA] Spanish Federation of Haemophilia (FEDHEMO), Spain. [Montoro JB] Vall d’Hebron Hospital Universitari, Barcelona, Spain</dc:contributor>
   <dc:contributor>Vall d'Hebron Barcelona Hospital Campus</dc:contributor>
   <dc:subject>Teràpia genètica</dc:subject>
   <dc:subject>Sang - Coagulació - Trastorns - Tractament</dc:subject>
   <dc:subject>Atenció centrada en el pacient</dc:subject>
   <dc:subject>ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Biological Therapy::Genetic Therapy</dc:subject>
   <dc:subject>DISEASES::Hemic and Lymphatic Diseases::Hematologic Diseases::Blood Coagulation Disorders::Blood Coagulation Disorders, Inherited::Hemophilia B</dc:subject>
   <dc:subject>Other subheadings::Other subheadings::/therapy</dc:subject>
   <dc:subject>HEALTH CARE::Health Services Administration::Patient Care Management::Comprehensive Health Care::Primary Health Care::Patient-Centered Care</dc:subject>
   <dc:subject>TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::terapia biológica::terapia genética</dc:subject>
   <dc:subject>ENFERMEDADES::enfermedades hematológicas y linfáticas::enfermedades hematológicas::trastornos de la coagulación sanguínea::trastornos de la coagulación sanguínea hereditarios::hemofilia B</dc:subject>
   <dc:subject>Otros calificadores::Otros calificadores::/terapia</dc:subject>
   <dc:subject>ATENCIÓN DE SALUD::administración de los servicios de salud::gestión de la atención al paciente::atención integral de salud::atención primaria de la salud::atención centrada en el paciente</dc:subject>
   <dc:description>Gene therapy; Haemophilia B; Patient journey roadmap</dc:description>
   <dc:description>Teràpia gènica; Hemofília B; Full de ruta del recorregut del pacient</dc:description>
   <dc:description>Terapia genética; Hemofilia B; Hoja de ruta del recorrido del paciente</dc:description>
   <dc:description>Background&#xd;
The approval of the first gene therapy for haemophilia B represents a disruptive innovation in its management. Its practical integration into the Spanish national healthcare system presents unique challenges and opportunities, requiring the development of a structured, coordinated and multidisciplinary patient journey roadmap to ensure high-quality patient care and outcomes measurement.&#xd;
Methods&#xd;
A multidisciplinary panel of 10 experts was established. The project involved a literature review, structured questionnaires, individual interviews, practical exercises and validation of results by focus group with nominal group methodology.&#xd;
Results&#xd;
No specific patient journey for haemophilia B or for gene therapy were identified in Spain. Associated changes required for current treatment of haemophilia B were identified and proposals made: 1) selection of candidates to receive gene therapy involves individualised assessment of eligibility criteria by a multidisciplinary committee including additional profiles; 2) providing adequate training on gene therapy to healthcare professionals is a must to ensure quality of care; 3) the generation of a specific informed consent document and processes involving hepatology and psychology are essential, with the patient association playing a crucial role; 4) centres without prior practical experience in gene therapy must adapt specific areas to ensure correct preparation and administration; 5) short- and long-term patient follow-up should incorporate continuous monitoring of the patient's liver health and inclusion in registries for evaluation of outcomes.</dc:description>
   <dc:description>This study was sponsored by CSL Behring.</dc:description>
   <dc:date>2025-05-07T07:25:57Z</dc:date>
   <dc:date>2025-05-07T07:25:57Z</dc:date>
   <dc:date>2025</dc:date>
   <dc:type>info:eu-repo/semantics/article</dc:type>
   <dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
   <dc:identifier>Álvarez-Román MT, Bonanad S, Herrera C, López R. M, Garcia-Diego DA, García S, et al. Proposal of an Integrated Patient Journey roadmap for the introduction of the first gene therapy for haemophilia B in Spain – The BHEMOGEN project. Rare. 2025;3:100078.</dc:identifier>
   <dc:identifier>2950-0087</dc:identifier>
   <dc:identifier>http://hdl.handle.net/11351/13045</dc:identifier>
   <dc:identifier>10.1016/j.rare.2025.100078</dc:identifier>
   <dc:identifier>http://hdl.handle.net/11351/13045</dc:identifier>
   <dc:language>eng</dc:language>
   <dc:relation>Rare;3</dc:relation>
   <dc:relation>https://doi.org/10.1016/j.rare.2025.100078</dc:relation>
   <dc:rights>Attribution-NonCommercial-NoDerivatives 4.0 International</dc:rights>
   <dc:rights>http://creativecommons.org/licenses/by-nc-nd/4.0/</dc:rights>
   <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
   <dc:format>application/pdf</dc:format>
   <dc:publisher>Elsevier</dc:publisher>
   <dc:source>Scientia</dc:source>
</oai_dc:dc></metadata></record></GetRecord></OAI-PMH>